Date: July 19, 2017. Watch the briefing video.
One of the most promising areas of cancer research is the
field of immuno-oncology. Scientists are discovering new ways to arm a
patient’s immune system so that it can attack cancer cells, and the result has
been one of the most transformative approaches to cancer treatment that has
ever entered the clinic. For many patients, cancer immunotherapies are
already providing lifesaving results where other treatments had failed or were
not viable. But realizing more breakthroughs in this area and broadening
the scope of cancers that can be treated with immuno-oncology requires a
sustained, federal investment in cancer research through the National
Institutes of Health and the National Cancer Institute.
The American Association for Cancer Research and the Society
for Immunotherapy of Cancer are pleased to host this briefing that will highlight
some of the exciting innovations that are being delivered through immuno-oncology,
illustrate the hope that these advances are bringing to cancer patients, and note the
challenges that still need to be overcome so that even more cancer patients can
benefit from these revolutionary treatments.